COMMUNIQUÉS West-GlobeNewswire

Anaptys to Provide Overview of ANB033, a CD122 antagonist, at Virtual Investor Event on Tuesday, Oct. 14
29/09/2025
SAN DIEGO, Sept. 29, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced it will host a virtual [...]
uniQure Announces Closing of Upsized Public Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares
29/09/2025
LEXINGTON, Mass. and AMSTERDAM, Sept. 29, 2025 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced [...]
Cogent Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
29/09/2025
WALTHAM, Mass. and BOULDER, Colo., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today [...]
ARS Pharmaceuticals Secures Up to $250 Million Loan Facility with RA Capital Management and OMERS Life Sciences to Accelerate U.S. Commercialization of neffy®
29/09/2025
Initial $100 million term loan to propel market share growth in the U.S. SAN DIEGO, Sept. 29, 2025 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a commercial-stage biopharmaceutical company dedicated to [...]
ImmuCell Announces Selection of its Next President and CEO
29/09/2025
PORTLAND, Maine, Sept. 29, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and [...]
Abivax Announces Acceptance of Additional Late-Breaking Abstract from the ABTECT Phase 3 Induction Trials to be Presented at 2025 United European Gastroenterology (UEG) Meeting
29/09/2025
Abivax Announces Acceptance of Additional Late-Breaking Abstract from the ABTECT Phase 3 Induction Trials to be Presented at 2025 United European Gastroenterology (UEG) Meeting Late Breaking Abstract titled EFFICACY AND [...]
SciSparc: N2OFF Shareholders Approve Merger with SciSparc’s Majority Owned Subsidiary MitoCareX, a Drug Discovery Company Targeting Resistant Cancers Including Pancreatic and Non-Small Cell Lung Cancer
29/09/2025
TEL AVIV, Israel, Sept. 29, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (the "Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat [...]
Metsera Reports Positive Phase 2b Results for First- and Best-in-Class Ultra-long Acting GLP-1 RA Candidate MET-097i, Enabling Rapid Transition into Phase 3
29/09/2025
Placebo-subtracted mean weight loss up to 14.1% after 28 weeks with no plateau Potential for best-in-class tolerability with minimal diarrhea signal, 13% nausea, and 11% vomiting High study and treatment retention in [...]
Septerna Appoints Veteran Biotechnology Leader Keith Gottesdiener, M.D., to its Board of Directors
29/09/2025
SOUTH SAN FRANCISCO, Calif., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Septerna, Inc. (NASDAQ: SEPN), a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) drug discovery, today [...]
Kura Oncology and Kyowa Kirin Announce First Patient Dosed in Pivotal Phase 3 KOMET-017 Trial of Ziftomenib for Frontline Acute Myeloid Leukemia (AML)
29/09/2025
– KOMET-017-IC trial of intensive chemotherapy combination will assess MRD negative CR and EFS as dual-primary endpoints to support potential U.S. accelerated and full approval – – KOMET-017-NIC trial of venetoclax / [...]
Arcutis Biotherapeutics to Host Virtual Investor Day and Report Third Quarter 2025 Financial Results on October 28, 2025
29/09/2025
WESTLAKE VILLAGE, Calif., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on immuno-dermatology, today announced that it will report [...]
Persephone Biosciences Co-Sponsors Event With Clean Label Project At Annual American Academy Of Pediatrics Conference
29/09/2025
Persephone’s Daily Synergistic Synbiotic Is The First Synbiotic To Receive Clean Label Project First 1,000 Days Promise Certification DENVER, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Persephone Biosciences , a pioneering [...]
Glo & Spa-rkle Aesthetics and Medical Spa Launches Revolutionary Near-Painless and Precise PRP and PRF Hair Restoration Intradermal Injector Treatment
29/09/2025
Introducing Mesogun Intradermal Injection Technology for a Painless and Precise Hair Restoration Experience Lubbock, TX, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Glo & Spa-rkle Aesthetics and Medical Spa, a leading name [...]
Compass Health CEO honored with Lifetime Achievement Award from Vistage, the world’s largest CEO coaching and advisory organization
29/09/2025
The Lifetime Achievement Award recognizes a veteran member of 10+ years with a track record of bold decisions benefitting the company, community and beyond EVERETT, Wash., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Compass [...]
Lighthouse Autism Center Announces Expansion in North Carolina with High Point Location
29/09/2025
ABA Provider Expands in North Carolina to Meet Growing Need for Autism Services MISHAWAKA, Ind., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Lighthouse Autism Center, a premier provider of center-based Applied Behavior Analysis [...]
Silo Pharma Updates Strategic Agreement with Fireblocks to Secure Crypto Treasury Management
29/09/2025
Fireblocks is a globally recognized leader in the digital assets space, facilitating the secure transfer of more than $10 trillion to date SARASOTA, FL, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO [...]
Vivos Inc Board Authorizes Vivos Inc to Establish a Corporate Entity in India
29/09/2025
Kennewick, WA, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL) The Vivos Board granted authorization to form a wholly owned corporate subsidiary in India. Vivos Inc filed for the name of Vivos Scientific [...]
Fagron increases share capital through exercise subscription rights
29/09/2025
Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 29 September 2025 – 7PM CET Fagron increases share capital through exercise subscription rights Fagron announces that as a result of the exercise of [...]
Tria Federal Unveils Tria Forge, a Serverless AI Platform That Empowers Organizations to Build Secure, Codeless AI Tools
29/09/2025
ARLINGTON, Va., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Tria Federal today announced the launch of Tria Forge , a secure, serverless generative AI platform that empowers customers to build and deploy AI tools tailored to [...]

Pages